Incyte
INCY
#1201
Rank
$19.62 B
Marketcap
$98.22
Share price
-0.78%
Change (1 day)
46.03%
Change (1 year)

Incyte (INCY) - Net assets

Net assets on the balance sheet as of March 2026 : $5.62 Billion USD

According to Incyte's latest financial reports the company has $5.62 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Incyte - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$$5.16 B49.89%
2024-12-31$$3.44 B-33.57%
2023-12-31$$5.18 B18.76%
2022-12-31$$4.37 B15.92%
2021-12-31$$3.77 B44.37%
2020-12-31$$2.61 B0.49%
2019-12-31$$2.59 B34.91%
2018-12-31$$1.92 B18.11%
2017-12-31$$1.63 B288.74%
2016-12-31$$0.41 B145.08%
2015-12-31$$0.17 B-309.68%
2014-12-31$-$81.63 Million-57.73%
2013-12-31$-$0.2 Billion10.37%
2012-12-31$-$0.18 Billion-22.95%
2011-12-31$-$0.23 Billion156.17%
2010-12-31$-$88.65 Million-13.42%
2009-12-31$-$0.11 Billion-53.62%
2008-12-31$-$0.23 Billion38.39%
2007-12-31$-$0.16 Billion87.87%
2006-12-31$-$84.91 Million337.74%
2005-12-31$-$19.4 Million-124.7%
2004-12-31$$78.51 M-49.12%
2003-12-31$$0.15 B-48.97%
2002-12-31$$0.30 B-31.3%
2001-12-31$$0.44 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
$38.92 B 592.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$90.40 B 1,507.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$31.19 B 454.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.19 B 63.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.99 B-82.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
$0.22 B-95.98%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-$25.35 Million-100.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
$28.84 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
$0.14 B-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA